KPTI Historical Earnings image   This KPTI historical earnings page last updated 11/7/2022
KPTI Historical Revenue
PeriodHistorical Earnings DateGAAP
Q3 202211/3/20220.04B
Q2 20228/4/20220.04B
Q1 20225/5/20220.05B
Q4 20212/8/20220.13B
Q3 202111/3/20210.04B
Q2 20218/5/20210.02B
Q1 20215/3/20210.02B
Q4 20202/11/20210.04B
Q3 202011/2/20200.02B
Q2 20208/4/20200.03B
Q1 20205/5/20200.02B
Q4 20192/13/20200.02B
Q3 201911/4/201913.15M
Q2 20198/6/20190.01B
Q1 20195/9/20190.00B
Q4 20182/28/2019206000
Q3 201811/8/2018239000
Q2 20188/7/201819.89M
Q1 20185/10/201810.00M
Q4 20173/15/20181.53M
Q3 201711/2/2017NA
Q2 20178/8/20173000
Q1 20175/4/201768000
Q4 20163/16/201747000
Q3 201611/7/201648000
Q2 20168/4/201659000
Q1 20165/9/2016NA
Q4 20153/14/201625000
Q3 201511/9/201575000
Q2 20158/10/2015150000
Q1 20155/11/2015NA
Q4 20143/16/201516000
Q3 201411/10/201421000
Q2 20148/7/201421.00M
Q1 20145/7/2014171.00M
KPTI Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q3 202211/3/2022-0.450
Q2 20228/4/2022-0.620
Q1 20225/5/2022-0.530
Q4 20212/8/20220.460
Q3 202111/3/2021-0.690
Q2 20218/5/2021-0.710
Q1 20215/3/2021-0.770
Q4 20202/11/2021-0.590
Q3 202011/2/2020-0.730
Q2 20208/4/2020-0.630
Q1 20205/5/2020-0.780
Q4 20192/13/2020-0.760
Q3 201911/4/2019-0.670
Q2 20198/6/2019-0.710
Q1 20195/9/2019-1.090
Q4 20182/28/2019-0.96
Q3 201811/8/2018-0.79
Q2 20188/7/2018-0.6
Q1 20185/10/2018-0.78
Q4 20173/15/2018-0.8
Q3 201711/2/2017-0.65
Q2 20178/8/2017-0.64
Q1 20175/4/2017-0.71
Q4 20163/16/2017-0.65
Q3 201611/7/2016-0.69
Q2 20168/4/2016-0.84
Q1 20165/9/2016-0.75
Q4 20153/14/2016-0.81
Q3 201511/9/2015-0.85
Q2 20158/10/2015-0.92
Q1 20155/11/2015-0.74
Q4 20143/16/2015-0.79
Q3 201411/10/2014-0.61
Q2 20148/7/2014-0.55
Q1 20145/7/2014-0.46
Quotes delayed 20 minutes

Email EnvelopeFree KPTI Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Karyopharm Therapeutics (KPTI) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

KRBP Historical Earnings
KRMD Historical Earnings
KRON Historical Earnings
KROS Historical Earnings
KRTX Historical Earnings
KRYS Historical Earnings
KTRA Historical Earnings
KTTA Historical Earnings
KURA Historical Earnings
KYMR Historical Earnings
What was the record high KPTI historical earnings result?
In terms of earnings or revenue, what is the best KPTI historical earnings result that Karyopharm Therapeutics has ever posted, and when?

✔️Accepted answer: Within our data set, the highest KPTI historical earnings result was set in Q4 2021, when Karyopharm Therapeutics posted results of 0.460/share. The most successful revenue quarter within our data set was Q1 2014 when Karyopharm Therapeutics reported revenue of 171.00M.

What was the lowest Karyopharm Therapeutics historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest KPTI has reported, and when?

✔️Accepted answer: Within our data set, the lowest KPTI historical earnings result was set in Q1 2019, when Karyopharm Therapeutics posted results of -1.090/share. The smallest revenue quarter within our data set was Q3 2017 when Karyopharm Therapeutics reported revenue of NA.

On this page we presented the KPTI historical earnings date information for Karyopharm Therapeutics. Reviewing that KPTI Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q4 2021, when KPTI posted gaap of 0.460/share. Meanwhile the lowest KPTI historical earnings result was in Q1 2019, when KPTI posted gaap of -1.090/share. Moving to Karyopharm Therapeuticss historical revenue numbers, the largest revenue quarter in our data set was seen in Q1 2014 when KPTI reported 171.00M in revenue, while the smallest revenue quarter was Q3 2017 when KPTI reported NA in revenue.

For self directed investors doing their due diligence on KPTI or any other given stock, their research can benefit from looking into all of the Karyopharm Therapeutics historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Karyopharm Therapeutics historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for KPTI. Thanks for visiting, and the next time you need to research KPTI historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: GATX Price Target, BL Average Annual Return, PKG RSI.

 

KPTI Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.